Teva announced the appointment of John Nason to president, Teva Active Pharmaceutical Ingredients (TAPI), a role in which he leads the company’s vertically integrated business unit responsible for the development, manufacture, marketing and sales of bulk API for both third-party manufacturers and for Teva.  Nason also assumes responsibility for the company’s biologics operations, which play an important role in the company’s long-term strategy. He will be based at Teva’s global headquarters i...